You have 9 free searches left this month | for more free features.

Overall Status

Not yet recruiting (15)

Recruiting (9)

Active, not recruiting (1)

Enrolling by invitation (1)

Sign in for free

Phase

phase 2 (22)

phase 1/phase 2 (2)

Collaborator

Study Documents

Intervention Type

drug (26)

procedure (2)

radiation (2)

Funder Type

Other (22)

Industry (4)

Study Type

Interventional (24)

Observational (2)

envafolimab

Showing 26 - 26 of 26

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Malignant Tumors Trial in Guangzhou (LM101, Toripalimab, Rituximab)

Recruiting

Malignant Tumors

LM101
+3 more

Guangzhou, Guangdong, China

Sun Yat-sen University Cancer Center

Jan 17, 2023